NOTO, ALESSANDRO
NOTO, ALESSANDRO
Universita' degli Studi di MILANO
Longitudinal Monitoring of Measurable Residual Disease in Chronic Lymphocytic Leukemia Patients Treated With Venetoclax: Results of a Prospective Multicenter Real-Life Study
2026 L. Farina, A. Noto, A. Aiello, M. Motta, A. Ferrario, R. Moia, L. Scarfò, M. Deodato, M. Merli, S. Ljevar, G. Pruneri, C. Carniti, P. Corradini
Why Do High-Risk Patients Develop or Not Develop Coronary Artery Disease? Metabolic Insights from the CAPIRE Study
2022 M. Deidda, A. Noto, C.C. Dessalvi, D. Andreini, F. Andreotti, E. Ferrannini, R. Latini, A.P. Maggioni, M. Magnoni, G. Mercuro
Use of GELSECTAN® in patients with irritable bowel syndrome (IBS): An Italian experience
2021 M. Bellini, G. Berti, L. Bonfrate, F. Ciranni, A. Di Ciaula, M. Di Ruscio, A. Dell'Era, C. Lambiase, A. Noto, A. Pancetti, P. Portincasa, F. Rettura
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy)
2020 B. Fattizzo, J.A. Giannotta, W. Barcellini, M.C. Barbanti, C. Bucelli, R. Cassin, D. Cattaneo, F. Cavallaro, V. Ferla, N.S. Fracchiolla, A. Freyrie, G. Galassi, M.C. Goldaniga, F.I. Grifoni, A. Iurlo, G. Mangiameli, V. Mattiello, M. Meli, A. Neri, A. Noto, F. Onida, L. Ottani, R. Pasquale, L. Pettine, A. Pompa, G. Reda, F.G. Rossi, G.N. Saporiti, M. Sciumè, E. Tagliaferri, L. Baldini